Conformational perturbation of SARS-CoV-2 spike protein using N-acetyl cysteine: an exploration of probable mechanism of action to combat COVID-19

被引：1

作者：

Debnath, Utsab ^{[1
]}

Mitra, Amrita ^{[2
]}

Dewaker, Varun ^{[3
]}

Prabhakar, Yenamandra S. ^{[3
]}

Tadala, Raghu ^{[4
]}

Krishnan, Kiran ^{[4
]}

Wagh, Padmakar ^{[4
]}

Velusamy, Umashankar ^{[4
]}

Baliyan, Aastha ^{[5
]}

Kurpad, Anura V. ^{[6
]}

Bhattacharyya, Parthasarathi ^{[7
]}

Mandal, Amit Kumar ^{[5
]}

机构：

[1] Univ Petr & Energy Studies, Sch Hlth Sci & Technol, Dehra Dun, India

[2] St Johns Res Inst, Div Mol Med, Clin Prote Unit, Bangalore, India

[3] CSIR, Cent Drug Res Inst, Med & Proc Chem Div, Lucknow, India

[4] Waters India Pvt Ltd 36A, Bengaluru, India

[5] Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Nadia 741246, W Bengal, India

[6] St Johns Med Coll, Dept Physiol, Bangalore, India

[7] Inst Pulmocare & Res, Clin Div, Kolkata, India

来源：

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS | 2024年 / 42卷 / 10期

关键词：

SARS-CoV-2; spike protein; disulfide bonds; N-acetyl cysteine (NAC); angiotensin-converting enzyme 2 (ACE2); mass spectrometry; proteomics; molecular docking; MD simulation; MOLECULAR-DYNAMICS; WEB SERVER; ANALOGS;

D O I：

10.1080/07391102.2023.2234031

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Spike protein is used to target human ACE2 receptor for viral fusion into the human cell. N-acetyl cysteine can interestingly inhibit this viral fusion process by increasing the probability of structural deformation of this viral spike protein. This process may indirectly reduce the intermolecular binding affinity between two enzymes

引用

页码：5042 / 5052

页数：11

共 50 条

[1] Evidence for SARS-CoV-2 Spike Protein in the Urine of COVID-19 Patients
George, Santosh
Pal, Anasuya Chattopadhyay
Gagnon, Jacqueline
Timalsina, Sushma
Singh, Pallavi
Vydyam, Pratap
Munshi, Muhammad
Chiu, Joy E.
Renard, Isaline
Harden, Christina A.
Ott, Isabel M.
Watkins, Anne E.
Vogels, Chantal B. F.
Lu, Peiwen
Tokuyama, Maria
Venkataraman, Arvind
Casanovas-Massana, Arnau
Wyllie, Anne L.
Rao, Veena
Campbell, Melissa
Farhadian, Shelli F.
Grubaugh, Nathan D.
Dela Cruz, Charles S.
Ko, Albert, I
Perez, Amalia Z. Berna
Akaho, Elikplim H.
Moledina, Dennis G.
Testani, Jeffrey
John, Audrey R.
Ledizet, Michel
Ben Mamoun, Choukri
KIDNEY360, 2021, 2 (06): : 924 - 936
[2] Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?
Jia, Zaixing
Gong, Wenping
JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (18)
[3] SARS-CoV-2 spike protein: Site-specific breakpoints for the development of COVID-19 vaccines
Velusamy, Palaniyandi
Kiruba, Kannan
Su, Chia-Hung
Arun, Viswanathan
Anbu, Periasamy
Gopinath, Subash C. B.
Vaseeharan, Baskaralingam
JOURNAL OF KING SAUD UNIVERSITY SCIENCE, 2021, 33 (08)
[4] Competitive cleavage of SARS-CoV-2 spike protein and epithelial sodium channel by plasmin as a potential mechanism for COVID-19 infection
Hou, Yapeng
Yu, Tong
Wang, Tingyu
Ding, Yan
Cui, Yong
Nie, Hongguang
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2022, 323 (05) : L569 - L577
[5] Small molecule stabilization of non-native protein-protein interactions of SARS-CoV-2 N protein as a mechanism of action against COVID-19
Fernandez, Julian F.
Lavecchia, Martin J.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (10) : 4488 - 4495
[6] Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19
Valenzuela-Fernandez, Agustin
Cabrera-Rodriguez, Romina
Ciuffreda, Laura
Perez-Yanes, Silvia
Estevez-Herrera, Judith
Gonzalez-Montelongo, Rafaela
Alcoba-Florez, Julia
Trujillo-Gonzalez, Rodrigo
Garcia-Martinez de Artola, Diego
Gil-Campesino, Helena
Diez-Gil, Oscar
Lorenzo-Salazar, Jose M.
Flores, Carlos
Garcia-Luis, Jonay
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2022, 10
[7] In Silico Discovery of GPCRs and GnRHRs as Novel Binding Receptors of SARS-CoV-2 Spike Protein Could Explain Neuroendocrine Disorders in COVID-19
Elkazzaz, Mahmoud
Ahmed, Amr
Abo-Amer, Yousry Esam-Eldin
Hydara, Tamer
Haikal, Abdullah
Razek, Dina N. Abd El
Eltayb, Wafa Ali
Wang, Xiling
Karpinski, Tomasz M.
Hamza, Dalia
Jabbar, Basit
Shamkh, Israa M.
VACCINES, 2022, 10 (09)
[8] In silico structural inhibition of ACE-2 binding site of SARS-CoV-2 and SARS-CoV-2 omicron spike protein by lectin antiviral dyad system to treat COVID-19
Pandey, Anand Kumar
Verma, Shalja
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2022, 48 (10) : 539 - 551
[9] Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19
Yuan Huang
Chan Yang
Xin-feng Xu
Wei Xu
Shu-wen Liu
Acta Pharmacologica Sinica, 2020, 41 : 1141 - 1149
[10] Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19
Huang, Yuan
Yang, Chan
Xu, Xin-feng
Xu, Wei
Liu, Shu-wen
ACTA PHARMACOLOGICA SINICA, 2020, 41 (09) : 1141 - 1149

← 1 2 3 4 5 →